Literature DB >> 24475854

Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.

Jennifer S McDonald1, Robert J McDonald, Rickey E Carter, Richard W Katzberg, David F Kallmes, Eric E Williamson.   

Abstract

PURPOSE: To determine the effect of baseline estimated glomerular filtration rate (eGFR) on the causal association between intravenous iodinated contrast material exposure and subsequent development of acute kidney injury (AKI) in propensity score-matched groups of patients who underwent contrast material-enhanced or unenhanced computed tomography (CT).
MATERIALS AND METHODS: This retrospective study was HIPAA compliant and institutional review board approved. All patients who underwent contrast-enhanced (contrast material group) or unenhanced (non-contrast material group) CT between 2000 and 2010 were identified and stratified according to baseline eGFR by using Kidney Disease Outcomes Quality Initiative cutoffs for chronic kidney disease into subgroups with eGFR of 90 or greater, 60-89, 30-59, and less than 30 mL/min/1.73 m(2). Propensity score generation and 1:1 matching of patients were performed in each eGFR subgroup. Incidence of AKI (serum creatinine [SCr] increase of ≥0.5 mg/dL [≥44.2 μmol/L] above baseline) was compared in the matched subgroups by using the Fisher exact test.
RESULTS: A total of 12 508 propensity score-matched patients with contrast-enhanced and unenhanced scans met all inclusion criteria. In this predominantly inpatient cohort, the incidence of AKI significantly increased with decreasing baseline eGFR (P < .0001). However, this incidence was not significantly different between contrast material and non-contrast material groups in any eGFR subgroup; for the subgroup with eGFR of 90 or greater (n = 1642), odds ratio (OR) was 0.91 (95% confidence interval [CI]: 0.38, 2.15), P = .82; for the subgroup with eGFR of 60-89 (n = 3870), OR was 1.03 (95% CI: 0.66, 1.60), P = .99; for the subgroup with eGFR of 30-59 (n = 5510), OR was 0.94 (95% CI: 0.76, 1.18), P = .65; and for the subgroup with eGFR of less than 30 mL/min/1.73 m(2) (n = 1486), OR was 0.97 (95% CI: 0.72, 1.30), P = .89.
CONCLUSION: Diminished eGFR is associated with an increased risk of SCr-defined AKI following CT examinations. However, the risk of AKI is independent of contrast material exposure, even in patients with eGFR of less than 30 mL/min/1.73 m(2). RSNA, 2014

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24475854     DOI: 10.1148/radiol.13130775

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  90 in total

Review 1.  Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention.

Authors:  Shu Min Tao; Julian L Wichmann; U Joseph Schoepf; Stephen R Fuller; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2015-12-18       Impact factor: 5.315

Review 2.  Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.

Authors:  Stephan Ehrmann; Andrew Quartin; Brian P Hobbs; Vincent Robert-Edan; Cynthia Cely; Cynthia Bell; Genevieve Lyons; Tai Pham; Roland Schein; Yimin Geng; Karim Lakhal; Chaan S Ng
Journal:  Intensive Care Med       Date:  2017-02-14       Impact factor: 17.440

3.  Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study.

Authors:  Jennifer S McDonald; Robert J McDonald; Eric E Williamson; David F Kallmes; Kianoush Kashani
Journal:  Intensive Care Med       Date:  2017-02-17       Impact factor: 17.440

4.  Feasibility of 320-row area detector CT coronary angiography using 40 mL of contrast material: assessment of image quality and diagnostic accuracy.

Authors:  Rihyeon Kim; Eun-Ah Park; Whal Lee; Jin Wook Chung
Journal:  Eur Radiol       Date:  2016-02-23       Impact factor: 5.315

5.  Imaging for appendicitis: should radiation-induced cancer risks affect modality selection?

Authors:  Sorapop Kiatpongsan; Lesley Meng; Jonathan D Eisenberg; Maurice Herring; Laura L Avery; Chung Yin Kong; Pari V Pandharipande
Journal:  Radiology       Date:  2014-07-01       Impact factor: 11.105

6.  Changing Paradigms in Contrast Nephropathy.

Authors:  Arnaldo Lopez-Ruiz; Kiran Chandrashekar; Luis A Juncos
Journal:  J Am Soc Nephrol       Date:  2017-01-19       Impact factor: 10.121

Review 7.  Noninvasive aortic imaging.

Authors:  Vinit Baliyan; Daniel Verdini; Nandini M Meyersohn
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 8.  Contrast medium induced acute kidney injury: a narrative review.

Authors:  Valentina Pistolesi; Giuseppe Regolisti; Santo Morabito; Ilaria Gandolfini; Silvia Corrado; Giovanni Piotti; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

9.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

10.  Image quality, radiation dose, and diagnostic accuracy of prospectively ECG-triggered high-pitch coronary CT angiography at 70 kVp in a clinical setting: comparison with invasive coronary angiography.

Authors:  Long Jiang Zhang; Yining Wang; U Joseph Schoepf; Felix G Meinel; Richard R Bayer; Li Qi; Jian Cao; Chang Sheng Zhou; Yan E Zhao; Xie Li; Jian Bin Gong; Zhengyu Jin; Guang Ming Lu
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.